139 related articles for article (PubMed ID: 2326653)
1. Metastatic neuroblastoma: new abnormalities on bone scintigraphy may not indicate tumour recurrence.
Hall-Craggs MA; Shaw D; Pritchard J; Gordon I
Skeletal Radiol; 1990; 19(1):33-6. PubMed ID: 2326653
[TBL] [Abstract][Full Text] [Related]
2. Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma.
Macdonald WB; Stevens MM; Dalla Pozza L; Bergin M; Menser MA; Howman-Giles R; Uren RF
J Nucl Med; 1993 Jul; 34(7):1082-6. PubMed ID: 8315482
[TBL] [Abstract][Full Text] [Related]
3. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
Shulkin BL; Shapiro B; Hutchinson RJ
J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
[TBL] [Abstract][Full Text] [Related]
4. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
Barai S; Bandopadhayaya GP; Malhotra A; Agarwal S; Kumar R; Dhanapathi H
J Postgrad Med; 2004; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
[TBL] [Abstract][Full Text] [Related]
5. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
Sautter-Bihl ML; Bihl H; Heinze HG
Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
[TBL] [Abstract][Full Text] [Related]
6. False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma.
Ozcan Z; Erenel G; Aksoylar S; Kansoy S; Burak Z; Ozkiliç H
Clin Nucl Med; 1999 Apr; 24(4):267-70. PubMed ID: 10466525
[TBL] [Abstract][Full Text] [Related]
7. Bone scans in neuroblastoma.
Bhogate BM; Samuel AM; Ramanathan P
Indian J Cancer; 1993 Mar; 30(1):5-9. PubMed ID: 8500809
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma presenting clinically as hip osteomyelitis: a "signature" diagnosis on skeletal scintigraphy.
Applegate K; Connolly LP; Treves ST
Pediatr Radiol; 1995 Nov; 25 Suppl 1():S93-6. PubMed ID: 8577566
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the utility of
Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
[TBL] [Abstract][Full Text] [Related]
10. Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDP.
Podrasky AE; Stark DD; Hattner RS; Gooding CA; Moss AA
AJR Am J Roentgenol; 1983 Sep; 141(3):469-72. PubMed ID: 6224402
[TBL] [Abstract][Full Text] [Related]
11. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
[TBL] [Abstract][Full Text] [Related]
12. The complementary role of sequential 99mTc-MDP and 67Ga-citrate scanning in the diagnosis and follow-up of neuroblastoma.
Garty I; Koren A; Goshen Y; Siplovich L
Eur J Nucl Med; 1985; 11(6-7):224-9. PubMed ID: 3865771
[TBL] [Abstract][Full Text] [Related]
13. Extraosseous uptake of technetium-99m MDP in secondary deposits of neuroblastoma.
Mandell GA; Heyman S
Clin Nucl Med; 1986 May; 11(5):337-40. PubMed ID: 3698433
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
[TBL] [Abstract][Full Text] [Related]
15. Extraosseous uptake of 99mtechnetium methylene diphosphonate: neuroblastoma or radiation therapy.
Sty JR; Kun L; Casper J; Babbitt DP
Pediatr Radiol; 1980; 9(1):53-4. PubMed ID: 7352114
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of morphological/immunohistochemical versus nuclear medicine imaging modalities in detecting metastatic bone and/or marrow deposits in neuroblastoma patients.
Zaher Ael-S; Zaher AM; Moneer MM; El Gamal BM
J Egypt Natl Canc Inst; 2011 Jun; 23(2):79-88. PubMed ID: 22099965
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy.
Sharma R; Mondal A; Bhatnagar A; Chakravarty KL; Mishra P; Chopra MK; Rawat HS; Kashyap R
Clin Nucl Med; 1998 Nov; 23(11):758-63. PubMed ID: 9814564
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of malignant and degenerative bone lesions using dexamethasone interventional 3- and 24-hour bone scintigraphy.
Bhatnagar A; Mondal A; Kashyap R; Sharma RK; Sharma R; Chakravarty SK; Bihari V; Sawroop K; Chopra MK; Soni NL
Eur J Nucl Med; 1994 Jul; 21(7):609-14. PubMed ID: 7957346
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
Parisi MT; Greene MK; Dykes TM; Moraldo TV; Sandler ED; Hattner RS
Invest Radiol; 1992 Oct; 27(10):768-73. PubMed ID: 1399431
[TBL] [Abstract][Full Text] [Related]
20. [Scintigraphy in the diagnosis and follow-up of bone neoplasms in childhood].
Silvestro L; Testa A; Mussa GC
Minerva Pediatr; 1987 May; 39(10):463-70. PubMed ID: 2821371
[No Abstract] [Full Text] [Related]
[Next] [New Search]
